within Pharmacolibrary.Drugs.ATC.A;

model A14AA02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 4.1666666666666665e-05,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0016666666666666668,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A14AA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Stanozolol is a synthetic anabolic-androgenic steroid derived from dihydrotestosterone, historically used to treat hereditary angioedema and stimulate muscle growth in certain wasting disorders. It has been misused as a performance-enhancing drug and is now rarely approved for medical use due to its side effects and potential for abuse.</p><h4>Pharmacokinetics</h4><p>Estimated oral pharmacokinetics in healthy adult males. No direct peer-reviewed publication with full PK model parameters available, so parameters based on literature review and data summary.</p><h4>References</h4><ol><li><p>Olson, ME, et al., &amp; Quinn, KB (2000). The effect of stanozolol on 15nitrogen retention in the dog. <i>Canadian journal of veterinary research = Revue canadienne de recherche veterinaire</i> 64(4) 246–248. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11041505/&quot;>https://pubmed.ncbi.nlm.nih.gov/11041505</a></p></li><li><p>Ahi, S, et al., &amp; Jain, S (2009). Detection of mono-hydroxylated metabolites of stanozolol by HPLC-ESI (+) MS/MS in Indian sports persons. <i>Drug testing and analysis</i> 1(11-12) 538–544. DOI:<a href=&quot;https://doi.org/10.1002/dta.76&quot;>10.1002/dta.76</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20355170/&quot;>https://pubmed.ncbi.nlm.nih.gov/20355170</a></p></li><li><p>Massé, R, et al., &amp; Dugal, R (1989). Studies on anabolic steroids. III. Detection and characterization of stanozolol urinary metabolites in humans by gas chromatography-mass spectrometry. <i>Journal of chromatography</i> 497 17–37. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2625454/&quot;>https://pubmed.ncbi.nlm.nih.gov/2625454</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A14AA02;
